<VariationArchive VariationID="1805601" VariationName="NM_000380.4(XPA):c.640dup (p.Met214fs)" VariationType="Duplication" Accession="VCV001805601" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862612" VariationID="1805601">
      <GeneList>
        <Gene Symbol="XPA" FullName="XPA, DNA damage recognition and repair factor" GeneID="7507" HGNC_ID="HGNC:12814" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97654398" stop="97697340" display_start="97654398" display_stop="97697340" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100437190" stop="100459690" display_start="100437190" display_stop="100459690" Strand="-" />
          </Location>
          <OMIM>611153</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000380.4(XPA):c.640dup (p.Met214fs)</Name>
      <CanonicalSPDI>NC_000009.12:97684955:TTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97684955" stop="97684956" display_start="97684955" display_stop="97684956" variantLength="1" positionVCF="97684955" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100447237" stop="100447238" display_start="100447237" display_stop="100447238" variantLength="1" positionVCF="100447237" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>M172fs</ProteinChange>
      <ProteinChange>M214fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.100447243dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.100447243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.97684961dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.97684961dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011642.1" sequenceAccession="NG_011642" sequenceVersion="1" change="g.17454dup">
            <Expression>NG_011642.1:g.17454dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.4" sequenceAccession="NM_000380" sequenceVersion="4" change="c.640dup" MANESelect="true">
            <Expression>NM_000380.4:c.640dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000371.1" sequenceAccession="NP_000371" sequenceVersion="1" change="p.Met214fs">
            <Expression>NP_000371.1:p.Met214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354975.2" sequenceAccession="NM_001354975" sequenceVersion="2" change="c.514dup">
            <Expression>NM_001354975.2:c.514dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341904.1" sequenceAccession="NP_001341904" sequenceVersion="1" change="p.Met172fs">
            <Expression>NP_001341904.1:p.Met172fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027302.2" sequenceAccession="NR_027302" sequenceVersion="2" change="n.688dup">
            <Expression>NR_027302.2:n.688dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149091.2" sequenceAccession="NR_149091" sequenceVersion="2" change="n.416dup">
            <Expression>NR_149091.2:n.416dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149092.2" sequenceAccession="NR_149092" sequenceVersion="2" change="n.582dup">
            <Expression>NR_149092.2:n.582dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149093.2" sequenceAccession="NR_149093" sequenceVersion="2" change="n.688dup">
            <Expression>NR_149093.2:n.688dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149094.2" sequenceAccession="NR_149094" sequenceVersion="2" change="n.582dup">
            <Expression>NR_149094.2:n.582dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.3" sequenceAccession="NM_000380" sequenceVersion="3" change="c.640dupA">
            <Expression>NM_000380.3:c.640dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_471" sequenceAccession="LRG_471">
            <Expression>LRG_471:g.17454dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_471t1" sequenceAccession="LRG_471t1">
            <Expression>LRG_471t1:c.635dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_471p1" sequenceAccession="LRG_471p1" change="p.Met214Asnfs">
            <Expression>LRG_471p1:p.Met214Asnfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000380.4(XPA):c.640dup (p.Met214fs) AND Xeroderma pigmentosum group A" Accession="RCV002472019" Version="2">
        <ClassifiedConditionList TraitSetID="263">
          <ClassifiedCondition DB="MedGen" ID="C0268135">Xeroderma pigmentosum group A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26884178</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="263" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9685" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, complementation group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum group A</ElementValue>
                <XRef ID="MONDO:0010210" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, type 1</ElementValue>
                <XRef ID="Xeroderma+pigmentosum%2C+type+1/7566" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XPA</ElementValue>
                <XRef Type="MIM" ID="278700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XP1</ElementValue>
                <XRef Type="MIM" ID="278700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">XPA-Related Xeroderma Pigmentosum</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5624" />
                <XRef ID="5624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0268135" DB="MedGen" />
              <XRef ID="MONDO:0010210" DB="MONDO" />
              <XRef Type="MIM" ID="278700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414073" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000380_3_XPA_c_640dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767752" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26884178</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v0.6.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0205 - Variant is predicted to result in a truncated protein with less than 1/3 of the protein affected (exon 5 of 6). (P) 0301 - Variant is absent from gnomAD. (P) 0701 – Multiple comparable variants have very strong previous evidence for pathogenicity. ClinVar has more than 5 truncated protein reported pathogenic. (P) 0803 - Low previous evidence of pathogenicity in unrelated individuals (1 homozygous patient reported with XPA; PMID:26884178). (P) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant in a recessive disease. (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2592</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000380.3:c.640dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010210" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5414073" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010210" MappingRef="MONDO">
        <MedGen CUI="C0268135" Name="Xeroderma pigmentosum group A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

